MwanzoTWST • NASDAQ
add
Twist Bioscience Corp
$ 47.59
Baada ya Saa za Kazi:(0.50%)+0.24
$ 47.83
Imefungwa: 14 Feb, 19:41:25 GMT -5 · USD · NASDAQ · Kanusho
Bei iliyotangulia
$ 46.87
Bei za siku
$ 46.81 - $ 48.34
Bei za mwaka
$ 27.41 - $ 60.90
Thamani ya kampuni katika soko
2.84B USD
Wastani wa hisa zilizouzwa
elfu 834.89
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 88.71M | 24.08% |
Matumizi ya uendeshaji wa biashara | 77.48M | 2.03% |
Mapato halisi | -31.59M | 26.54% |
Kiwango cha faida halisi | -35.61 | 40.80% |
Mapato kwa kila hisa | -0.53 | 29.33% |
EBITDA | -28.26M | 27.17% |
Asilimia ya kodi ya mapato | -0.31% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 270.83M | -12.96% |
Jumla ya mali | 608.58M | -16.95% |
Jumla ya dhima | 152.64M | 6.91% |
Jumla ya hisa | 455.94M | — |
hisa zilizosalia | 59.65M | — |
Uwiano wa bei na thamani | 6.13 | — |
Faida inayotokana na mali | -14.16% | — |
Faida inayotokana mtaji | -15.80% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -31.59M | 26.54% |
Pesa kutokana na shughuli | -21.43M | 6.73% |
Pesa kutokana na uwekezaji | -1.54M | -136.88% |
Pesa kutokana na ufadhili | 17.94M | 1,318.19% |
Mabadiliko halisi ya pesa taslimu | -5.07M | 74.84% |
Mtiririko huru wa pesa | -11.25M | -3.00% |
Kuhusu
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
2013
Tovuti
Wafanyakazi
923
